Visalytics
Visalytics
approved EB-2 (NIW)

Physician Scientist

Molecular Biology · China · 2025-03-13

Processing Time
27 days
Decision Date
2025-03-13
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to focus on repurposing existing drugs for cancer treatment by leveraging advanced computational methods and bioinformatics tools. This work aims to enhance therapeutic options, improve patient outcomes, and significantly reduce the time and cost associated with traditional drug development.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses a pressing national need in healthcare by offering efficient solutions for combating cancer.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic background and publication record demonstrate the necessary expertise to lead the proposed research.

3 Waiver Benefit to the US Met

The potential for reducing drug development costs and improving patient outcomes makes waiving the labor certification beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in human medicine and a strong record of 8 peer-reviewed journal articles, 2 conference articles, and 1 first-authored abstract. These works garnered 15 citations, demonstrating scientific impact. The case was supported by 2 expert recommendation letters and satisfied all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Original Contributions

Similar Cases

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Indiana 296 days 2025-02-24
The petitioner proposes to develop targeted cancer therapeutics and precision-based therapeutic options to prevent the recurrence of malignant diseases. The work focuses on creating cost-effective, personalized, and immunological therapies to simplify cancer diagnosis and treatment. The endeavor aims to improve treatment outcomes, reduce side effects, and lower long-term healthcare costs in the United States.
View Case

Postdoctoral Researcher

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Illinois 535 days 2026-01-16
The petitioner proposes to continue research in clinical pharmaceutical sciences, specifically focusing on understanding cancer development at the molecular level. The work involves investigating mechanisms such as genome instability and replication stress to identify actionable molecular targets for cost-conscious therapeutic strategies.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-13.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 27 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist